Literature DB >> 27076345

Placental Ischemia and Resultant Phenotype in Animal Models of Preeclampsia.

Babbette LaMarca1, Lorena M Amaral2, Ashlyn C Harmon2, Denise C Cornelius2, Jessica L Faulkner2, Mark W Cunningham2.   

Abstract

Preeclampsia is new onset (or worsening of preexisting) hypertension that occurs during pregnancy. It is accompanied by chronic inflammation, intrauterine growth restriction, elevated anti-angiogenic factors, and can occur with or without proteinuria. Although the exact etiology is unknown, it is thought that preeclampsia begins early in gestation with reduced uterine spiral artery remodeling leading to decreased vasculogenesis of the placenta as the pregnancy progresses. Soluble factors, stimulated by the ischemic placenta, shower the maternal vascular endothelium and are thought to cause endothelial dysfunction and to contribute to the development of hypertension during pregnancy. Due to the difficulty in studying such soluble factors in pregnant women, various animal models have been designed. Studies from these models have contributed to a better understanding of how factors released in response to placental ischemia may lead to increased blood pressure and reduced fetal weight during pregnancy. This review will highlight various animal models and the major findings indicating the importance of placental ischemia to lead to the pathophysiology observed in preeclamptic patients.

Entities:  

Keywords:  Animal models; Hypertension; Inflammation; Preeclampsia; Pregnancy

Mesh:

Year:  2016        PMID: 27076345      PMCID: PMC5127437          DOI: 10.1007/s11906-016-0633-x

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  112 in total

Review 1.  Fetal tolerance in human pregnancy--a crucial balance between acceptance and limitation of trophoblast invasion.

Authors:  Ulrike von Rango
Journal:  Immunol Lett       Date:  2007-11-05       Impact factor: 3.685

2.  Autoantibody-mediated angiotensin receptor activation contributes to preeclampsia through tumor necrosis factor-alpha signaling.

Authors:  Roxanna A Irani; Yujin Zhang; Cissy Chenyi Zhou; Sean C Blackwell; M John Hicks; Susan M Ramin; Rodney E Kellems; Yang Xia
Journal:  Hypertension       Date:  2010-03-29       Impact factor: 10.190

3.  The unique pathophysiology of early-onset severe preeclampsia: role of decidual T regulatory cells.

Authors:  Kristen H Quinn; D Yvette Lacoursiere; Li Cui; Jack Bui; Mana M Parast
Journal:  J Reprod Immunol       Date:  2011-07-23       Impact factor: 4.054

4.  Agonistic angiotensin II type 1 receptor autoantibodies in postpartum women with a history of preeclampsia.

Authors:  Carl A Hubel; Gerd Wallukat; Myles Wolf; Florian Herse; Augustine Rajakumar; James M Roberts; Nina Markovic; Ravi Thadhani; Friedrich C Luft; Ralf Dechend
Journal:  Hypertension       Date:  2007-01-08       Impact factor: 10.190

Review 5.  Angiotensin II type 1 receptor autoantibody (AT1-AA)-mediated pregnancy hypertension.

Authors:  Florian Herse; Babbette LaMarca
Journal:  Am J Reprod Immunol       Date:  2012-12-28       Impact factor: 3.886

6.  Role of reactive oxygen species in hypertension produced by reduced uterine perfusion in pregnant rats.

Authors:  Mona Sedeek; Jeffrey S Gilbert; Babbette B LaMarca; Myssara Sholook; Derrick L Chandler; Yuping Wang; Joey P Granger
Journal:  Am J Hypertens       Date:  2008-07-31       Impact factor: 2.689

7.  Hypertension in response to autoantibodies to the angiotensin II type I receptor (AT1-AA) in pregnant rats: role of endothelin-1.

Authors:  Babbette LaMarca; Marc Parrish; Lillian Fournier Ray; Sydney R Murphy; Lyndsay Roberts; Porter Glover; Gerd Wallukat; Katrin Wenzel; Kathy Cockrell; James N Martin; Michael J Ryan; Ralf Dechend
Journal:  Hypertension       Date:  2009-08-24       Impact factor: 10.190

8.  Uterine vascular function in a transgenic preeclampsia rat model.

Authors:  Stefan Verlohren; Manuela Niehoff; Lydia Hering; Nele Geusens; Florian Herse; Andrei N Tintu; Andreas Plagemann; Ferdinand LeNoble; Robert Pijnenborg; Dominik N Muller; Friedrich C Luft; Joachim W Dudenhausen; Maik Gollasch; Ralf Dechend
Journal:  Hypertension       Date:  2008-01-14       Impact factor: 10.190

9.  Systemic increase in the ratio between Foxp3+ and IL-17-producing CD4+ T cells in healthy pregnancy but not in preeclampsia.

Authors:  Brigitte Santner-Nanan; Michael John Peek; Roma Khanam; Luise Richarts; Erhua Zhu; Barbara Fazekas de St Groth; Ralph Nanan
Journal:  J Immunol       Date:  2009-11-13       Impact factor: 5.422

Review 10.  Pathophysiology of hypertension in response to placental ischemia during pregnancy: a central role for endothelin?

Authors:  Babbette D LaMarca; Barbara T Alexander; Jeffery S Gilbert; Michael J Ryan; Mona Sedeek; Sydney R Murphy; Joey P Granger
Journal:  Gend Med       Date:  2008
View more
  19 in total

1.  Melanocortin-4 Receptor Deficiency Attenuates Placental Ischemia-Induced Hypertension in Pregnant Rats.

Authors:  Frank T Spradley; Ana C Palei; Christopher D Anderson; Joey P Granger
Journal:  Hypertension       Date:  2019-01       Impact factor: 10.190

Review 2.  Vitamin D administration during pregnancy as prevention for pregnancy, neonatal and postnatal complications.

Authors:  Carol L Wagner; Bruce W Hollis; Kalliopi Kotsa; Hana Fakhoury; Spyridon N Karras
Journal:  Rev Endocr Metab Disord       Date:  2017-09       Impact factor: 6.514

3.  Tumor necrosis factor alpha (TNF-α) blockade improves natural killer cell (NK) activation, hypertension, and mitochondrial oxidative stress in a preclinical rat model of preeclampsia.

Authors:  Mark W Cunningham; Aswathi Jayaram; Evangeline Deer; Lorena M Amaral; Venkata Ramana Vaka; Tarek Ibrahim; Denise C Cornelius; Babbette LaMarca
Journal:  Hypertens Pregnancy       Date:  2020-07-10       Impact factor: 2.108

4.  A novel rodent model of pregnancy complications associated with genetically determined angiotensin-converting enzyme (ACE) activity.

Authors:  Eugenia Mata-Greenwood; Arlin B Blood; LeeAnna D Sands; Shannon L Bragg; Daliao Xiao; Lubo Zhang
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-01-23       Impact factor: 4.310

5.  In utero exposure to transient ischemia-hypoxemia promotes long-term neurodevelopmental abnormalities in male rat offspring.

Authors:  Arvind Palanisamy; Tusar Giri; Jia Jiang; Annie Bice; James D Quirk; Sara B Conyers; Susan E Maloney; Nandini Raghuraman; Adam Q Bauer; Joel R Garbow; David F Wozniak
Journal:  JCI Insight       Date:  2020-05-21

6.  Vascular Endothelial Growth Factor Delivery to Placental Basal Plate Promotes Uterine Artery Remodeling in the Primate.

Authors:  Jeffery S Babischkin; Graham W Aberdeen; Jonathan R Lindner; Thomas W Bonagura; Gerald J Pepe; Eugene D Albrecht
Journal:  Endocrinology       Date:  2019-06-01       Impact factor: 4.736

7.  AT1-AA (Angiotensin II Type 1 Receptor Agonistic Autoantibody) Blockade Prevents Preeclamptic Symptoms in Placental Ischemic Rats.

Authors:  Mark W Cunningham; Javier Castillo; Tarek Ibrahim; Denise C Cornelius; Nathan Campbell; Lorena Amaral; Venkata Ramana Vaka; Nathan Usry; Jan M Williams; Babbette LaMarca
Journal:  Hypertension       Date:  2018-03-19       Impact factor: 10.190

Review 8.  Risk of cardiovascular disease, end-stage renal disease, and stroke in postpartum women and their fetuses after a hypertensive pregnancy.

Authors:  Mark W Cunningham; Babbette LaMarca
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2018-06-13       Impact factor: 3.619

Review 9.  Sex-Specific Contributions of Endothelin to Hypertension.

Authors:  Eman Y Gohar; David M Pollock
Journal:  Curr Hypertens Rep       Date:  2018-06-08       Impact factor: 5.369

10.  Luteolin-induced vasorelaxation in uterine arteries from normal pregnant rats.

Authors:  Weiwei Yang; Qinghua Li; Jeremy W Duncan; Bhavisha A Bakrania; Jessica L Bradshaw; Joey P Granger; Sarosh Rana; Frank T Spradley
Journal:  Pregnancy Hypertens       Date:  2020-10-23       Impact factor: 2.899

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.